Infectious Disease Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Introduction

Summary

Infectious Disease Research Institute (IDRI) is a non-profit healthcare institute that provides various pharmaceutical products and services. The institute provides vaccines, adjuvants, therapeutics, drugs and diagnostics services for several infectious diseases and conducts researches. It offers programs for the treatment of tuberculosis, leishmaniasis, leprosy, malaria, pandemic influenza and chagas disease and leprosy. IDRI offers cGMP services such as manufacturing, analytical methods, stability studies and process and contact. The institute collaborates in the areas of antigen discovery. The institute partners with nonprofits, various businesses, foundations and government agencies. IDRI is headquartered in Seattle, Washington, the US.

Infectious Disease Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Infectious Disease Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

• Table of Contents

  Table of Contents 3

  List of Tables 4

  List of Figures 4

  Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

  Infectious Disease Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

  Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

  Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

  Infectious Disease Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

  Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

  Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deal Details 11

  Partnerships 11

  Infectious Disease Research Institute Enters into Agreement with Zhejiang Hisun Pharma 11

  IDRI and NanoPass Tech Enter into Development Agreement 12

  Quratis Enters into Agreement with Infectious Disease Research Institute 13

  Infectious Disease Research Institute and Yonsei University Medical Center Form Joint Venture 14

  Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 15

  Jubilant Chemsys Enters into Research Agreement with Infectious Disease Research Institute 16

  IDRI And Zydus Cadila Healthcare Enter Into Agreement To Develop Vaccine Candidate For Visceral Leishmaniasis 17

  Soligenix Enters Into Agreement With Infectious Disease Research Institute To Develop Biodefense Vaccines 18

  Aeras Enters Into Co-Development Agreement With Infectious Disease Research Institute For ID93/GLA-SE 20

  Infectious Disease Research Institute - Key Competitors 21

  Infectious Disease Research Institute - Key Employees 22

  Infectious Disease Research Institute - Locations And Subsidiaries 23

  Head Office 23

  Other Locations & Subsidiaries 23

  Joint Venture 23

  Recent Developments 24

  Strategy And Business Planning 24

  May 20, 2018: GC Pharma to Establish Curevo - a Seattle-based New Company Dedicated to Development of New Vaccines 24

  Corporate Communications 25

  Jan 05, 2017: IDRI Expands Board of Directors with Former FDA Leader Norman Baylor 25

  Appendix 26

  Methodology 26

  About GlobalData 26

  Contact Us 26

  Disclaimer 26

List Of Tables
in Infectious Disease Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Tables

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Key Facts, 2016 2

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Infectious Disease Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Infectious Disease Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8

Infectious Disease Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Infectious Disease Research Institute Enters into Agreement with Zhejiang Hisun Pharma 11

IDRI and NanoPass Tech Enter into Development Agreement 12

Quratis Enters into Agreement with Infectious Disease Research Institute 13

Infectious Disease Research Institute and Yonsei University Medical Center Form Joint Venture 14

Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 15

Jubilant Chemsys Enters into Research Agreement with Infectious Disease Research Institute 16

IDRI And Zydus Cadila Healthcare Enter Into Agreement To Develop Vaccine Candidate For Visceral Leishmaniasis 17

Soligenix Enters Into Agreement With Infectious Disease Research Institute To Develop Biodefense Vaccines 18

Aeras Enters Into Co-Development Agreement With Infectious Disease Research Institute For ID93/GLA-SE 20

Infectious Disease Research Institute, Key Competitors 21

Infectious Disease Research Institute, Key Employees 22

Infectious Disease Research Institute, Joint Venture 23

List Of Figures, Charts and Diagrams
in Infectious Disease Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

List of Figures

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Infectious Disease Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Infectious Disease Research Institute, Medical Devices Deals, 2012 to YTD 2018 9

Additional Details

Publisher

Global Data

Publisher Information

Reference

224639 | GDPH63160D

Number of Pages

26

Report Format

PDF

Related Reports